title: Fibronectin protects endotoxin-induced liver injury after partial hepatectomy in rats.
abstract: Endotoxemia following extended hepatectomy may be a cause of postoperative death. Multiple organ failure related to septemia is a common cause of early mortality after liver transplantation. Fibronectins (Fns) are involved in cellular adhesion, motility, differentiation, apoptosis, hemostasis, wound healing, and ischemic injury. Studies were performed to determine whether Fn influences the survival rate of rats subjected to endotoxin-induced liver injury after partial hepatectomy. Male Sprague-Dawley rats were intravenously administered lipopolysaccharide (LPS) 48 hours after 70% hepatectomy. Prior to LPS administration, plasma Fn or bovine serum albumin was given intravenously. The survival rate of the Fn-treated group was higher than that of the controls. Fn prevented increases in serum enzyme activity and total bilirubin related to liver injury. The levels of inflammatory cytokines including tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 interferon-gamma were also significantly lower in the Fn-treated than the control group. Furthermore, the number of apoptotic cells and the degree of necrosis in the remnant liver were significantly decreased in the Fn-treated rats compared with controls. These results indicate that Fn prevents endotoxin-induced liver injury after partial hepatectomy, at least in part through inhibiting the production of inflammatory cytokines, and the necrosis apoptosis in the remaining liver.
authors.affiliation: Department of Surgery, Kansai Medical University, Osaka, Japan. kon@takii.kmu.ac.jp
authors.forename: A-H
authors.initials: AH
authors.lastname: Kwon
authors.forename: H
authors.initials: H
authors.lastname: Tsuchiya
authors.forename: Z
authors.initials: Z
authors.lastname: Qiu
authors.forename: H
authors.initials: H
authors.lastname: Yanagimoto
authors.forename: M
authors.initials: M
authors.lastname: Kaibori
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D004731:Endotoxins / Q000633:toxicity*; D005353:Fibronectins / Q000494:pharmacology*; D006498:Hepatectomy; D006801:Humans; D020287:In Situ Nick-End Labeling; D007375:Interleukin-1 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008297:Male; D023421:Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D004731:Endotoxins; D005353:Fibronectins; D007375:Interleukin-1; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha